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ABSTRACT 
Background: Permanent His bundle pacing (HBP) is a physiological alternative to right 
ventricular pacing (RVP). It is not known whether HBP can cause His-Purkinje conduction 
(HPC) disease. The aim of our study is to assess His bundle capture and its effect on LV 
function in long-term follow-up and to determine HPC at the time of pulse generator change 
(GC) in patients with chronic HBP. 
Methods: HB electrograms were recorded from the pacing lead at implant and GC. HBP 
QRS duration(d), HV intervals and HB pacing thresholds at GC were compared with implant 
measurements. HPC was assessed by pacing at cycle lengths of 700, 600 and 500ms at GC. 
LV internal diameters, EF and valve dysfunction at baseline were compared with 
echocardiography during follow-up. 
Results: GC was performed in 20 patients (men 13; age 74±14yrs) with HBP at 70±24 
months post implant. HV intervals remained unchanged from initial implant (44±4ms vs 
45±4 ms). During HBP at 700, 600 and 500 ms (n=17), consistent 1:1 HPC was present. HBP 
QRSd remained unchanged during follow-up (117±20 vs 118±23 ms). HBP threshold at 
implant and GC was 1.9±1.1V and 2.5±1.2V @ 0.5 ms. Despite high pacing burden 
(77±13%), there was a no significant change in LVEF (50±14% at implant) during follow-up 
(55±6%, p=0.06). 
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Conclusions: HBP does not appear to cause new HPC abnormalities and is associated with 
stable HBP QRSd during long-term follow-up. Despite high pacing burden, HBP did not 
result in deterioration of left ventricular systolic function or cause new valve dysfunction. 
Keywords: His bundle pacing; long-term follow-up; His-Purkinje conduction; LV function 
INTRODUCTION 
RV pacing has been associated with ventricular dyssynchrony, reduction in left ventricular 
ejection fraction and adverse clinical outcomes.
1,2,3
 Permanent His bundle pacing (HBP) is a
physiologic alternative to right ventricular (RV) pacing. Deshmukh et al,
4
 first described
successful permanent His-Bundle pacing (HBP) in a small series of patients with AF and 
dilated cardiomyopathy in 2000.  Subsequently, there have been multiple reports on 
permanent HBP, which have demonstrated it is feasible and associated with an improvement 
in exercise capacity, myocardial perfusion, ventricular synchrony and left ventricular ejection 
fraction (LVEF) compared to RV pacing.
5,6,7,8,9
 Despite these studies, permanent HBP has not
gained widespread acceptance in clinical practice due to a variety of reasons:  perceived 
difficulties associated with HBP lead implantation, lead dislodgement, and concern for 
progression in AV conduction system disease. Fibrosis is known to occur near the tip of the 
actively fixed RV leads. Concern that fibrosis will compromise reliable His bundle capture is 
one additional factor limiting broad adoption of permanent His bundle pacing. Long-term 
follow-up of permanent HBP has not been reported in the literature. The aim of our study is 
to assess His bundle capture and its effect on LV function in medium to long-term follow-up 
and to determine His-Purkinje conduction at the time of pulse generator change in patients 
with chronic HBP. 
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METHODS 
Patients: Permanent HBP has been performed at Geisinger Wyoming Valley Medical Center 
since 2006. Our analysis involved patients who had undergone successful permanent HBP 
between the years 2006 to 2014 and presented subsequently for generator change due to 
routine battery depletion. All patients provided written informed consent prior to 
implantation. This was a retrospective study approved by the institutional review board. 
Implantation technique: A detailed description of the permanent HBP has been described 
previously.
9
 Briefly, a 4.1 Fr bipolar active fixation lead (SelectSecure, model 3830,
Medtronic) was implanted in the His bundle region using a dedicated delivery sheath 
(deflectable C304 or C315His, Medtronic). Selective HBP (S-HBP) was defined as 
ventricular activation occurring solely over the His-Purkinje system: (1) His-Purkinje 
mediated cardiac activation and repolarization as evidenced by electrocardiographic (ECG) 
concordance of QRS and T wave complexes; (2) the paced-ventricular interval was almost 
identical to the His-ventricular interval (figure 1). Non-selective HBP was (NS-HBP) was 
defined based on capture of basal ventricular septum in addition to His bundle capture as: (1) 
no isoelectric interval between pacing stimulus and QRS; (2) the electrical axis of the paced 
QRS must be concordant with the electrical axis of the spontaneous QRS (if known); (3) 
narrowing of QRS with higher output or vice-versa (figure 2).
10,11,12
 The HBP lead was
connected to the RV port (no back-up lead) or the left ventricular port in a patient with CRT 
device (RV lead in RV port). Our definition of nonselective-HBP is different from the initial 
description of para-hisian pacing
4,13
 to eliminate the confusion associated with using para-
hisian capture
14
 in reference to assessment of accessory pathway conduction.
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Protocol: His bundle capture threshold, R wave amplitudes, pacing impedances and HV 
intervals were measured at implant. Twelve lead EKG at baseline and during HBP, along 
with baseline and paced QRS duration were also recorded for each patient. In patients with 
sinus node dysfunction, ventricular pacing avoidance algorithm was routinely used. Patients 
were followed in device clinic at 2 weeks, 2 months, 1 year and yearly thereafter. R wave 
amplitudes, pacing thresholds, and lead impedances were recorded at each visit. Patients were 
also followed by remote monitoring every 3 months. Any significant increases in pacing 
threshold, lead dislodgement or loss of capture were routinely tracked. Percentage right 
ventricular pacing (His bundle pacing) was recorded. At the time pulse generator change, His 
bundle capture threshold, R wave amplitudes, pacing impedances and HV intervals from the 
HBP lead were again measured. In addition, pacing from HBP lead was routinely performed 
at cycle lengths of 700, 600 and 500 ms to assess for 1:1 His bundle capture and 
conduction,
15
 during generator change (figure 3).
Echocardiography: All patients underwent echocardiography prior to their initial permanent 
pacemaker implantation. Follow-up echocardiograms were obtained as clinically indicated 
and prior to pacemaker generator change. LVEF was measured using Simpson’s biplane
method. In situations of poor image quality, EF measurements were supplemented by visual 
assessment by the echocardiographer. Left ventricular internal diameters at systole and 
diastole were obtained. Mitral and tricuspid regurgitation if present were reported as mild, 
moderate or severe. 
Follow-up: Urgent care visits or hospitalization for heart failure during follow-up were 
documented. Any new development of atrial fibrillation was recorded. 
Statistical analysis 
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Continuous data are presented as mean ± standard deviation. Differences between continuous 
variables were assessed using paired Student’s t test. The statistical significance was defined 
as a p value <0.05. 
RESULTS 
Patient Characteristics: Between the years 2006 to 2014, a total of 425 patients underwent 
HBP at our institution. Of these, twenty consecutive patients with previously successful 
permanent HBP presented for pulse generator change due to battery depletion and were 
included in our analysis. Baseline clinical characteristics along with findings at the time of 
generator change are summarized in Table 1. The primary indication for permanent pacing 
was AV nodal disease (second or third degree AV block) in 12, intra-Hisian block in 1 (HV), 
sinus node dysfunction in 5, failed LV lead placement in 1, and AV node ablation in 1. A 
dual chamber pacemaker was implanted in 15, single chamber in 1, CRT-P in 1 and CRT-D 
in 3 patients. Mean age 74±14 years; men 65%; hypertension 65%; diabetes 10%; coronary 
artery disease 40%, atrial fibrillation 65%; and cardiomyopathy 30%. The mean duration of 
permanent HBP at the time of generator change was 70±24 months (range: 36 – 102 months).
Pacing Characteristics: Selective HBP was achieved in 7 (35%) patients and nonselective 
HBP in 13 (65%). Baseline QRS duration was 102±27 ms and the paced (HBP) QRS duration 
prolonged to 117±20 ms at implant (p=0.04). At the time of generator change, the paced QRS 
duration and morphology did not differ significantly when compared to at implant (118±23 
ms, p=0.5). His bundle capture threshold at implant was 1.95±1.1V @ 0.5 ms. At the time of 
generator change, the HBP threshold was higher at 2.5±1.2V @ 0.5 ms (p=0.02). His bundle 
capture thresholds in patients with selective and nonselective HBP were not significantly 
different at implant (1.6±0.5 vs 2.1±1.3V, p=0.2) or at generator change (2.4±1.0 vs 
2.5±1.3V, p=0.7).   In one patient (18), HBP threshold increased significantly from 1.2V at 
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implant to 4.5V at the time of generator change, 36 months post implant (CRT-D). The HBP 
lead was removed by manual traction without difficulty and a new HBP lead was successfully 
implanted in this patient (HBP threshold 1V). There were no significant differences in the 
sensing amplitude (5.9±5.1 mV, range 1-10.1mV vs 6.1±3.9 mV, range 1.1-14 mV; p=0.43) 
or pacing impedance (516±98 vs 484±112 Ohms; p=0.06) at the time of generator change 
compared to implantation in the entire group. Overall ventricular pacing (HBP) burden 
during last follow-up was 77±13%. In the 5 patients with primary sinus node dysfunction, 
overall HBP burden was low at 14±19% with the use of minimal ventricular pacing
Tm
algorithm (range: 1-47%). In five patients with pacemaker model EnRhythm
Tm
 (Medtronic
Inc, Minneapolis, MN), there was premature battery depletion (advisory) despite low 
ventricular pacing burden in 4 patients (patient 9,15,17 and 20). 
His-Purkinje conduction: HV intervals at the time of implant were 44±4 ms and did not 
change significantly at the time of generator change (45±4 ms, n =19, p=0.5). At the time of 
generator change HBP was performed at 700,600 and 500 ms in 17 patients to assess distal 
His-Purkinje conduction. In all 17 patients tested, 1:1 His capture and conduction was present 
during pacing at 500 ms (figure 4). 
Echocardiographic data: Baseline and follow-up echocardiograms were available in all 
patients. Baseline LV ejection fraction (EF) was 50±14% and during last follow-up the EF 
was 55±6% (p=0.06) (figure 5). In the six patients with LV dysfunction at baseline, the 
ejection fraction improved from 36±12% to 50±7% during last follow-up (p=0.03). Left 
ventricular end-diastolic diameter improved from 51±8 mm at baseline to 47±7 mm at last 
follow-up (p=0.06). Mitral regurgitation was present in 11 patients (mild 10, moderate 1) and 
tricuspid regurgitation (mild 7, moderate 1) in 8 patients at baseline. Only one patient with 
underlying chronic obstructive pulmonary disease and pulmonary hypertension, showed 
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evidence of worsening tricuspid regurgitation (patient 1) from mild at baseline to moderate 
during follow-up in spite of improved LVEF from 35% at implant to 54%. No patient showed 
worsening mitral regurgitation. 
Clinical Outcome: Two patients (2 and 16) had a heart failure hospitalization (HFH) during 
follow-up. In patient 2, HFH was secondary to worsening renal function from diabetic 
nephropathy (serum Cr 2.4 mg/dl). Patient 2 also developed new persistent atrial fibrillation 
during follow-up. Diastolic dysfunction and dietary indiscretion was attributed to the heart 
failure admission 2 years after AV node ablation and HBP in patient 16, whose baseline 
LVEF had improved from 25 to 45%. Patient 6 had developed an inferior wall myocardial 
infarction with subsequent decline in his LVEF from 58 to 44%. 
DISCUSSION 
In this study, we present medium to long-term follow-up on 20 patients with permanent HBP 
who presented for generator change. This allowed us a unique opportunity to assess the 
effects of long term HBP on pacing characteristics and His-Purkinje conduction.  During a 
mean follow-up of 70±24 months, His bundle capture thresholds remained relatively stable 
with only a modest increase in pacing output (0.6V). One of the concerns of permanent HBP 
had been historically high pacing thresholds and early battery depletion. Despite the average 
pacing thresholds similar to those reported by other investigators,
16,17
 the device longevity
was longer in this series. Most investigators used a back-up RV pacing lead, thus requiring a 
biventricular or dual chamber device leading to additional battery depletion. We did not 
routinely place a back-up RV lead thus limiting current drain. Early in our experience, we 
programmed a pacing output twice the safety margin. Subsequently we changed our approach 
to program a pacing output at 1V above chronic His bundle capture (3 month) threshold at 1 
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ms pulse duration. In seven of these patients we had used the largest battery available from 
the manufacturer (Adapta L and EnRhythm
Tm
, Medtronic Inc, Minneapolis, MN) to combat
early battery depletion. Unfortunately, five of these devices had an advisory for premature 
battery depletion, despite minimal ventricular pacing in 4. Midway through this series, we 
learned to use the C315His sheath for implanting the His bundle pacing lead, which generally 
provides better pacing thresholds than those obtained using the C304 sheath.
9
 Currently we
are able to obtain lower His bundle capture thresholds in >50% of the patients by 
demonstrating acute His bundle injury current at implant.
18
 In addition, our current practice is
to primarily use the larger battery device. 
Early HBP implanters used an additional RV pacing lead in most patients because of low R 
wave sensing, high His pacing thresholds and concern for “what if they develop conduction 
disease distal to the AV node in the His –Purkinje system”. To our knowledge there is no
documented literature on the natural history of progression of conduction disease in AV 
nodal block.  An important observation in our study was the stability of His-Purkinje 
conduction and the His bundle paced QRS duration in this series. The HV interval remained 
unchanged from baseline. None of these patients developed new His-Purkinje conduction 
disease during follow-up. The paced QRS duration and the morphology at the time of GC 
were similar to the paced QRS at implant. When paced at 500 ms, 1:1 His capture and 
conduction remained unchanged. Even in the one patient (13) with intra-Hisian AV block, 
distal His capture was persistent. Recent reports suggest stable distal His-Purkinje conduction 
in patients with intra-Hisian block during medium term follow-up.
19,20
 It is not known
whether patients with AV nodal block develop disease in the His-Purkinje fibers in the future. 
In this small series we did not find any discernible evidence to suggest development of new 
His-Purkinje disease in patients with AV nodal block. Historical concerns regarding local 
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fibrosis and development of new His-Purkinje conduction disease should not be a deterrent 
for broad adoption of permanent HBP in clinical practice. 
It is well established that chronic right ventricular pacing is detrimental to left 
ventricular function and is associated with heart failure and increased mortality.
1,2,3
 While
biventricular pacing is beneficial compared to RV pacing in patients with heart failure,
21
 it
has not been proven to prevent HFH or improve mortality in patients without LV dysfunction 
or heart failure.
22,23
 However, in patients with systolic heart failure and QRS duration <130-
150 msec, HFH or mortality do not improve with biventricular pacing and even show 
worsening of their condition.
24,25
. In these cases, His bundle pacing may be effective in
ameliorating heart failure. 
 In our series, there was a non-significant increase in left ventricular ejection fraction 
during long-term follow-up despite high HBP burden (77%). This was primarily due to a 
significant increase in EF in the 6 patients with underlying LV dysfunction (p = 0.02). The 
improvement in LVEF could be attributed to HBP in 4 pts (LBBB 1, pacing induced 
cardiomyopathy 1, AF related in 2). In the 16 patients with normal LV function, EF remained 
unchanged (p = 0.96). Previous studies have shown that permanent HBP maintains LV 
synchrony, left ventricular performance, myocardial perfusion and prevent heart failure 
during short and medium term follow-up compared to right ventricular pacing.
4,5,6,7,17
 Several
small series have shown improvement in LV function with permanent HBP in patients with 
traditional indication for cardiac resynchronization therapy (CRT).
26,27
 It is possible that HBP
may provide alternative option for patients requiring CRT. In addition, our study shows that 
there is no significant worsening of valve regurgitation. The HBP lead is primarily located in 
the right atrium with minimal or no interference to the tricuspid valve.
28,29,30
 Right ventricular
pacing has been associated with new tricuspid regurgitation and valve abnormalities due to 
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fibrous lesions between the lead and the tricuspid valve in addition to pulmonary 
hypertension resulting from LV dysfunction.
31
 A recent study showed reduced incidence of
tricuspid valve abnormalities and venous stenosis with the Medtronic 3830 pacing lead 
compared to traditional RV pacing leads attributed to the smaller lead diameter (4.1 Fr).
32
During the entire follow-up period there were only two heart failure hospitalizations in our 
series despite high HBP burden. In a study of 304 patients with normal LV function and AV 
block, Zhang et al,
33
 showed that 26% of patients developed new onset heart failure during a
median follow-up of 7.8 years of right ventricular pacing. Both of our patients with HFH 
(patient 2 and 16) had selective HBP and improved LV function at the time of their 
hospitalization. It is unlikely that HBP contributed to the heart failure hospitalization in these 
patients. It is likely that permanent HBP may provide an excellent option for the majority of 
patients requiring ventricular pacing in the future. 
Limitations 
This was a small, single center, retrospective, observational series of selected patients with 
successful permanent His bundle pacing without comparisons of clinical outcomes with RV 
pacing. The small sample size also limits the statistical analysis. However this is the first 
study to report on long-term follow-up and clinical outcomes of permanent HBP. A 
randomized, multicenter evaluation of HBP compared to RV pacing with long-term follow-
up is necessary to prove the superiority of permanent HBP. Because capture thresholds with 
permanent HBP are still higher than a standard RV lead, improvement in lead designs, 
(longer helix), delivery sheaths, and new devices with longer battery life would be necessary. 
CONCLUSIONS 
Permanent HBP does not appear to cause new His-Purkinje conduction abnormalities during 
long-term follow-up. HV intervals, His bundle paced QRS duration, 1:1 His capture and 
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conduction remained stable during long-term follow-up. Despite high pacing burden, HBP 
did not result in deterioration of left ventricular systolic function or cause new valve 
dysfunction. 
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FIGURE LEGENDS 
Figure 1: A. Twelve lead ECG of patient 2 at baseline shows sinus bradycardia and long first 
degree AV block. B.  AV sequential pacing with selective His bundle capture at implant with 
paced QRS duration and morphology identical to baseline. C. Eight years later following 
generator change, ECG demonstrating persistent selective HBP with underlying atrial 
fibrillation. The stimulus to QRS interval is unchanged from implant. Note the significant 
morphology changes in aVF and V3 during HBP, which may be indicative of a latent His 
Purkinje conduction abnormality brought out by pacing, i.e. intraventricular conduction 
delay, despite maintenance of a narrow QRS throughout. 
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Figure 2: A. Twelve lead ECG of patient 13 with longstanding LBBB of 8-year duration 
with QRS duration of 160 ms. B. High-grade 3:1 AV block with underlying LBBB. C. 
Nonselective HBP with QRS duration of 126 ms at 4 years following generator change. 
Figure 3: Twelve lead ECG and intracardiac electrogram from the HBP lead at the time of 
generator change in patient 6. A. Complete AV block and narrow complex escape rhythm 
with HV interval of 45 ms, unchanged from baseline after 5 years. B. Selective His bundle 
capture with QRS duration identical to the escape rhythm with 1:1 His capture and 
conduction during pacing at cycle lengths of 700, 600 and 500 ms. 
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Figure 4: Twelve lead ECG and intracardiac electrogram from the HBP lead at the time of 
generator change in patient 1. A. Atrial fibrillation with slow ventricular response. HV 
interval was unchanged from baseline after more than 8 years of HBP. B. Nonselective His 
bundle capture with minimal QRS fusion and 1:1 His bundle capture during pacing at cycle 
lengths of 700, 600 and 500 ms. 
Figure 5: Left ventricular ejection fraction (LVEF), LV end diastolic diameter, QRS duration 
and HV intervals at baseline compared to at the time of generator change. There was no 
statistical difference between the two groups. *The HBP QRS duration was significantly 
longer at implant and generator change (GC) when compared to baseline. 
Table 1: Patient Characteristics 
Pt 
# 
A
g
e 
S
e
x 
Co-
morbi
dities 
Indic
ation 
At Implant Time 
to 
Gener
ator 
Chan
ge 
(m) 
HB
P 
pac
ing 
% 
At Generator Change 
H
V 
(
m
s) 
QR
Sd 
(m
s) 
HB
P 
QR
Sd 
(m
s) 
H
B
P 
ty
pe 
HBP 
thres
hold 
@0.5
ms 
E
F 
(
%
) 
H
V 
(
m
s) 
HB
P 
QR
Sd 
(m
s) 
HBP 
thres
hold 
@0.5
ms 
E
F 
(
%
) 
1 78 M 
HTN, 
HF, 
CAD, AF 
AVB, 
AF 45 92 120 NS 2.75 35 102 99.6 45 124 3 54 
2 70 M 
HTN, 
CAD, AF 
AVB, 
SSS 45 90 100 S 1.6 50 101 98 45 102 2.2 60 
3 87 M HTN AVB 50 92 92 S 1.2 65 79 96 50 96 1.5 64 
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4 34 M 
CAD, 
ICM 
LBBB, 
CHF 50 142 100 S 1.6 25 41 85 50 102 2.2 41 
5 87 M 
HTN, 
CAD, 
ICM, AF 
AVB, 
CHF, 
RVP 45 180 130 NS 1.25 20 38 99.2 45 136 2 44 
6 93 M 
HTN, 
CAD, 
ICM AVB 45 86 92 S 1.2 58 67 100 45 86 2 44 
7 51 M AF 
AVB, 
SSS 40 92 92 S 1.7 55 84 99 40 94 1.75 55 
8 83 F HTN, AF 
AVB, 
AF 40 92 132 NS 1.5 65 91 98.9 40 136 2 63 
9 76 F AF SSS 40 120 160 NS 3.6 57 60 18.3 40 150 2 60 
10 84 M HTN AVB 50 90 130 NS 3.4 55 99 99.8 50 132 3.5 55 
11 89 F HTN, AF SSS 40 100 130 NS 0.5 55 99 47 40 134 1.5 55 
12 79 M 
CAD, 
CABG, 
AF 
AVB, 
SSS, AF 45 92 126 NS 0.6 60 55 95.9 45 130 0.8 60 
13 81 F HTN HVB 
HV
B 160 126 NS 1.4 55 43 100 
HV
B 126 2.1 60 
14 71 M 
CAD, 
CABG, 
MVR, 
AF 
AVB, 
SSS 50 86 86 S 2.6 60 49 92.8 50 88 2.5 59 
15 79 F HTN, AF SSS, AF 45 86 126 NS 2.5 60 100 3 45 126 4 55 
16 63 F 
HTN, 
AF, 
NICM, 
DM 
AVN 
abl, AF 45 90 130 NS 1 25 54 100 45 134 2 55 
17 63 M 
HTN, 
AF, DM SSS 50 96 136 NS 4 55 54 1 50 136 4.5 54 
18 69 F 
CAD, 
CABG, 
MVR, 
ICM AVB 45 86 86 S 1.2 40 36 100 45 90 4.5 50 
19 85 M HTN AVB 40 102 132 NS 4.3 55 96 100 40 132 5 60 
20 68 M 
AF, 
NICM SSS, AF 45 80 120 NS 1.2 45 57 3 45 124 0.8 55 
Me
an 
74
.5 44 
10
2.7 
11
7.3 1.95 
49
.7 70.3 76.8 45 
11
8.2 2.49 
55
.1 
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AF – atrial fibrillation; AVB – AV nodal block; AVN – AV node; CABG – coronary artery bypass
graft; CHF – congestive heat failure; DM – diabetes mellitus; EF: ejection fraction; HV – His-
ventricular; HVB – HV block; HBP – His bundle pacing; HTN – hypertension, ICM – ischemic
cardiomyopathy, LBBB – left bundle branch block; m – months; NICM – non-ischemic
cardiomyopathy; QRSd – QRS duration; RVP – right ventricular pacing; SSS – sick sinus
syndrome. 
